This week has seen a flurry of investment secured across the health tech space.
As reported yesterday by Health Tech World, startup Quibim is closing in on its goal to take precision medicine to the next level via advanced imaging technology after a US$50m fundraise.
Here, we round up the other big investment developments from the past week.
Drug discovery platform launches with $24.6 million in initial funding
Manas AI Inc., a startup leveraging AI to accelerate drug discovery, has launched with $24.6 million in initial funding.
The funding round was led by General Catalyst and Manas AI co-founder Reid Hoffman, with participation from Greylock Partners, where Hoffman served as a general partner until 2023.
Hoffman, the billionaire co-founder of LinkedIn, founded Manas AI alongside Siddhartha Mukherjee, a renowned cancer researcher and Pulitzer Prize-winning author.
Their goal is to use AI to streamline the development of new medicines, starting with cancer treatments before expanding to autoimmune diseases and rare conditions.
Neko Health raises $260m Series B
Neko Health, the preventative healthcare technology company co-founded by Hjalmar Nilsonne and Daniel Ek, has announced the completion of its $260m Series B funding.
As part of this funding round, BejulSomaia, Partner at Lightspeed Venture Partners will join the Board of Directors at Neko Health.
The non-invasive Neko Health Scan maps millions of health data points on the body – both inside and out – in just a few minutes.
It checks moles and marks across the body, symptoms of metabolic syndrome and risk factors for stroke and heart attack, along with blood sugar levels to assess pre-diabetes risk.
Muscle health tech secures $5m in Series A
Springbok Analytics has closed an oversubscribed $5 million Series A funding round for its AI-driven muscle scanning technology, designed to support athletes and those focused on longevity.
The company’s FDA-cleared AI platform transforms MRI scans into automated muscle health assessments, addressing key needs in life sciences, elite sports and longevity.
Springbok currently offers three rapid MRI muscle health scan options—lower extremity, core and full body—with total imaging times ranging from 10 to 35 minutes.
After the scan, images are processed by Springbok’s AI-based software and reviewed for quality.
Telemedicine clinic Hone Health closes $33m Series A funding and acquires ivee
Hone Health, a telehealth clinic specialising in preventative and proactive longevity care, has completed a $33M Series A funding round.
This brings Hone Health’s total funding to $39m.
The new investment will drive the company’s expansion into proactive and preventative longevity care for men and women while supporting its commitment to regulatory compliance and patient safety.
AVS completes a $36m Series B financing
Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL platform, has completed a Series B round of financing of $36m.
The funding will support the US peripheral commercial launch as well as US. coronary and carotid IDE trials for the company’s Pulse Intravascular Lithotripsy (PIVL) device.
AVS began enrolling patients in October 2024 in the POWER PAD II U.S. IDE trial.
The study will enrol up to 120 patients at 20 US sites and enrolment is expected to be completed mid-year 2025.
SafelyYou secures $43m in Series C funding for elder care AI solution
SafelyYou has announced the close of a $43 million Series C financing round led by Touring Capital, a growth stage firm focused on AI-powered SaaS startups.
The funding will support the company’s mission to help solve critical challenges in elder care, including how accurately and efficiently operators can predict residents’ care needs.
Foundation Capital, Omega Healthcare Investors, Inc., Founders Fund, Cross Creek, Samsung Next, and Qualcomm Ventures also contributed to the funding round.
This brings the total funding raised by SafelyYou to over $100 million.
